Beta blockers seem not to reduce risks more than one year after heart attack
May 04, 2023
Long-term beta blocker therapy was not associated with improved cardiovascular outcomes during a median follow-up period of 4.5 years, investigators report.
Clinical briefs for Thursday, May 4
By
Alicia Lasek
May 04, 2023
Providers tepidly embrace CMS plan to revoke ‘no longer needed’ vax mandate … Pandemic taking toll on RNs’ job satisfaction, mental health, survey finds … Survey reveals reasons behind older...
‘A different phase’: End of COVID-19 vax rule for healthcare workers
By
Alicia Lasek
May 02, 2023
A COVID-19 vaccination rule for healthcare workers that took full effect after a Supreme Court vote in early 2022 will soon be lifted, the Biden administration says.
Surgeon general tags loneliness as next public health threat
By
Alicia Lasek
May 03, 2023
The U.S. surgeon general on Tuesday declared loneliness, a condition linked to health comorbidities and premature death, an American epidemic requiring national action.
U.S. advisers recommend screening for latent tuberculosis
By
Alicia Lasek
May 03, 2023
The U.S. Preventive Services Task Force is recommending that clinicians screen for latent tuberculosis infection in at-risk adults, including those in congregate settings.
Clinical briefs for Wednesday, May 3
By
Alicia Lasek
May 03, 2023
Increase in mortality among whites may explain drop in COVID-19 disparities … AHA: Data show cognitive impairment is common after stroke … People with asthma 36% more likely to get cancer: study …...
CDC to end community tracking of COVID-19
By
Alicia Lasek
May 02, 2023
Community spread will no longer be tracked by the CDC after the PHE ends May 11. Nursing homes have used the data to make COVID-19 mitigation decisions.
Initiatives yield decline in antipsychotic use across resident racial, ethnic groups: study
By
Alicia Lasek
May 01, 2023
Declining exposure to the drugs has occurred evenly across nursing home resident racial and ethnic groups, according to a new study.
COVID-19 drug guards against all variants
May 02, 2023
Trial results for AstraZeneca’s experimental antibody, a potential replacement for Evusheld, could be out by September. The company is hoping for emergency use authorization by the end of 2023.
Clinical briefs for Tuesday, May 2
By
Alicia Lasek
May 01, 2023
Infectious disease experts urge Congress for new antibiotics, bolstered stewardship … 23 state attorneys general urge coverage of Alzheimer’s treatments … Senior living operator is first to seek...